BamSEC and AlphaSense Join Forces
Learn More

Mylan Inc.

Underwriting Agreements Filter

EX-1.1
from 8-K 38 pages Mylan Inc. $500,000,000 1.350% Senior Notes Due 2016 $500,000,000 2.550% Senior Notes Due 2019 $500,000,000 4.200% Senior Notes Due 2023 $500,000,000 5.400% Senior Notes Due 2043 Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.1
from 8-K 147 pages Mylan Inc. 7.625% Senior Notes Due 2017 7.875% Senior Notes Due 2020 Indenture Dated as of May 19, 2010 the Bank of New York Mellon as Trustee
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.1
from 8-K 38 pages Mylan Inc. (A Pennsylvania Corporation) 3.75% Cash Convertible Notes Due 2015 Purchase Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.2
from 8-K 54 pages Mylan Inc. (A Pennsylvania Corporation) 1,860,000 Shares of 6.50% Mandatory Convertible Preferred Stock Purchase Agreement
12/34/56
EX-1.1
from 8-K 52 pages Mylan Inc. (A Pennsylvania Corporation) 53,500,000 Shares of Common Stock Purchase Agreement
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.2
from 8-K 40 pages Mylan Laboratories Inc. (A Pennsylvania Corporation) 22,750,000 Shares of Common Stock Purchase Agreement
12/34/56
EX-1.1
from 8-K 40 pages Mylan Laboratories Inc. (A Pennsylvania Corporation) 1.25% Senior Convertible Notes Due 2012 Purchase Agreement
12/34/56